Neutrophils are a type of white blood cell. In fact, most of the white blood cells that lead the immune system's response are neutrophils. In your bloodstream, there are neutrophils that, when faced with a pathogenic threat, will expel their DNA like a net to contain it.
These DNA snares are called neutrophil extracellular traps or NETs. Researchers from Germany and the United States describe an important step in how these NETs are released and how they stop a fungus from establishing an infection in mice and human cells in the journal Developmental Cell.
Study Identifies How Immune Cells Cross the Blood-brain Barrier
Study shows for the first time in live animals in real-time, the different means by which two distinct immune cell types gain access to myelin and nerves.
Advertisement
‘Neutrophils are white blood cells that use their own DNA snares called neutrophil extracellular traps (NETs) as a last line of defense against pathogens.’
Tweet it Now
"This is basically a type of beneficial cell suicide," says first author Borko Amulic, a postdoc in the lab of Arturo Zychlinsky at the Max Planck Institute for Infection Biology and a newly appointed Lecturer at the University of Bristol. "When neutrophils get overwhelmed, when they can no longer deal with a microbial threat by just engulfing it, that's when the NETs are released."
Once a neutrophil is induced to release its NETs, it anchors itself in the tissue and breaks down its nuclear envelope: the barrier between the nuclear DNA and the rest of the cell. The researchers were intrigued by this, because normally cells only break down their nuclear envelope before they divide. Zychlinsky, Amulic, and colleagues hypothesized that neutrophils were using the same cell cycle proteins used for cell division to release the NETs.
![New Mechanism Can Disarm Attacking Immune Cells]( "New Mechanism Can Disarm Attacking Immune Cells")
A novel mechanism has been identified that is used by the pancreatic cancer cells to disarm macrophages, which attack immune cells.
To test this, the researchers inhibited the cell cycle proteins in mouse neutrophils, and found that indeed, fewer NETs were released. Consequently, mice that were no longer to efficiently release NETs were less able to clear fungal infections. Then, they observed human brains with fungal infections and confirmed that our neutrophils are also using cell cycle proteins.
"The ultimate goal for this research is to interfere clinically, either when too few or too many NETs are being produced," says Amulic. "Also, this is just a really fascinating cell biological phenomenon."
Source: Eurekalert
New Mechanism Can Disarm Attacking Immune Cells
A novel mechanism has been identified that is used by the pancreatic cancer cells to disarm macrophages, which attack immune cells.
Advertisement
To test this, the researchers inhibited the cell cycle proteins in mouse neutrophils, and found that indeed, fewer NETs were released. Consequently, mice that were no longer to efficiently release NETs were less able to clear fungal infections. Then, they observed human brains with fungal infections and confirmed that our neutrophils are also using cell cycle proteins.
"The ultimate goal for this research is to interfere clinically, either when too few or too many NETs are being produced," says Amulic. "Also, this is just a really fascinating cell biological phenomenon."
Source: Eurekalert
Here's Why Immune Cells Become Defective
Effector T-cells become impaired due to undifferentiated naïve T-cells that are been affected by cancer, which keeps the fighter cells from doing their job.
Advertisement
 Immune Cells May Help Treat Inflammatory Bowel DiseaseSpecific immune cells known as macrophages have the ability to secrete or produce a protective or healing factor known as Interleukin-10 (IL-10). | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
In Alzheimer's disease condition, the control and adjustment of ABCA7 levels in response to inflammation and the decrease in the availability of cholesterol.
Atopic dermatitis (AD) and inflammatory bowel disease (IBD) can lead to alterations in the microbiome, and disruptions in the skin and gut barrier.
Gaining insights into mortality risks among vitiligo patients will enhance patient counseling, healthcare monitoring, and overall patient management strategies.
Antimicrobial peptide SP1V3_1, from snake venom can eliminate antibiotic-resistant bacteria like E. coli, P. aeruginosa and among others.
